CTRI/2011/12/002271招募中1 期
Adjuvant Homoeopathic Management for breast cancer patients experiencing side effects from chemotherapy-An observational pilot study
Central Council for Research in Homoeopathy0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •?Females, 18 years or over, with any stage of any type of breast cancer undergoing chemotherapy
- •?Patient having any two of the following side effects of chemotherapy viz. nausea, vomiting, abdominal pain, diarrhea, constipation, decreased appetite, hair loss, fatigue reporting within 2 weeks of chemotherapy.
- •?Patient should not be under Homoeopathic treatment for the side effects of chemotherapy
- •?Patients able to take self care
- •?Patients willing to sign written informed consent
- •?Hb% more than 6.5 gm%
排除标准
- •?Inability to comply with the study protocol, including psychiatric disease
- •?Features of renal failure (urea more than 50 mg%, creatinine more than 2 mg %)
- •?Features of gastro intestinal obstruction
- •?Patients deemed ineligible by the investigator
研究者
相似试验
尚未招募
不适用
A study on the impact of pharmaceutical care on breast cancer patientsCTRI/2020/07/026688Self funded
进行中（未招募）
不适用
Preoperative treatment of breast cancer with a combination of epirubicin, docetaxel and bevacizumab. A translational trial on molecular markers and functional imaging to predict response early - PROMIXPatients diagnosed with breast cancer who are candidates for preoperative (neoadjuvant) chemotherapy due to localized primary breast cancer including inflammatory breast cancer suitable for primary medical treatment and/or regional lymph node metastases including ipsilateral supraclavicular nodes with breast cancer diagnosis confirmed by histological examination.MedDRA version: 9.1Level: LLTClassification code 10006200Term: Breast cancer stage IIMedDRA version: 9.1Level: LLTClassification code 10006201Term: Breast cancer stage IIIMedDRA version: 9.1Level: LLTClassification code 10021974Term: Inflammatory breast cancerEUCTR2007-005858-23-SEPROMIX Trial Group200
已完成
不适用
Treatment of breast cancer-associated lymphedema. A randomized study of the (cost-)effectiveness of manual lymphatic drainage and/or intermittent pneumatic compressioLymphedema100062911004079510025231NL-OMON30736Academisch Ziekenhuis Maastricht207
进行中（未招募）
不适用
Hormonothérapie adjuvante du cancer du sein : Pharmacocinétique du tamoxifène et des anti-aromatases, corrélation avec les caractéristiques pharmacogénétiquesProtocole PHACS (Pharmacologie de l’Hormonothérapie Adjuvante dans le Cancer du Sein) - PHACSCancer du sein en situation adjuvanteMedDRA version: 12.1Level: PTClassification code 10006187Term: Breast cancerEUCTR2009-018090-30-FRInstitut Claudius Regaud
招募中
不适用
Treatment of patients with breast cancer or gastrointestinal cancer and chemotherapy-induced polyneuropathia with whole body vibration (Galileo technology)Chemotherapy induced polyneuropathyG62Other polyneuropathiesDRKS00006181Klinik für Tumorbiologie50